Hyunjoon Park

Dr. Hyunjoon Park


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 September 2024 in Scientific Reports
Verified
Journal Article
Open access
PDF file
HPHyunjoon Park
Hyunjoon Park
SYSoyoung Yeo
Soyoung Yeo
CRChang Beom Ryu
Chang Beom Ryu
CHChul Sung Huh
Chul Sung Huh
Bacterial culturomics is a set of techniques to isolate and identify live bacteria from complex microbial ecosystems. Despite its potential to revolutionize microbiome research, bacterial culturomics has significant challenges when applied to human gut microbiome studies due to its labor-intensive nature. Therefore, we established a streamlined culturomics approach with minimal culture conditions for stool sample preincubation. We evaluated the suitability of non-selective medium candidates for maintaining microbial diversity during a 30-day incubation period based on 16S rRNA gene amplicon analysis. Subsequently, we applied four culture conditions (two preincubation media under an aerobic/anaerobic atmosphere) to isolate gut bacteria on a large scale from eight stool samples of healthy humans. We identified 8141 isolates, classified into 263 bacterial species, including 12 novel species candidates. Our analysis of cultivation efficiency revealed that seven days of aerobic and ten days of anaerobic incubation captured approximately 91% and 95% of the identified species within each condition, respectively, with a synergistic effect confirmed when selected preincubation media were combined. Moreover, our culturomics findings expanded the coverage of gut microbial diversity compared to 16S rRNA gene amplicon sequencing results. In conclusion, this study demonstrated the potential of a streamlined culturomics approach for the efficient isolation of gut bacteria from human stool samples. This approach might pave the way for the broader adoption of culturomics in human gut microbiome studies, ultimately leading to a more comprehensive understanding of this complex microbial ecosystem.

20 February 2025 in Frontiers in Microbiology
Verified
Journal Article
Open access
PDF file
HPHyunjoon Park
Hyunjoon Park
SYSoyoung Yeo
Soyoung Yeo
TLTaekyu Lee
Taekyu Lee
YHYumin Han
Yumin Han
CRChang Beom Ryu
Chang Beom Ryu
CHChul Sung Huh
Chul Sung Huh
Inflammatory bowel disease (IBD) is characterized by disruptions in the gut microbiome. While most studies on gut dysbiosis in IBD rely on sequencing-based methods, we employed a streamlined culturomics approach to obtain a more comprehensive understanding of gut microbiota imbalance in patients with IBD that may not be captured by sequencing alone. A total of 367 bacteria were identified at the species level, including 211 species from ulcerative colitis patients, 164 species from Crohn’s disease (CD) patients, and 263 species from healthy individuals. Consistent with our 16S rRNA gene amplicon sequencing results, a significant decrease in microbial diversity and a severe imbalance, especially in CD patients, were also observed in the culture-based analysis. Our culturomics approach provided additional insights, highlighting dysbiosis in unique anaerobic and Gram-negative species in CD patients. Moreover, species-level findings for Bifidobacterium and Enterobacterales emphasized specific species expansions in IBD patients. Notably, Mediterraneibacter gnavus, Thomasclavelia ramosa, Parabacteroides merdae, and Collinsella aerofaciens are of particular clinical interest due to their correlation with inflammatory biomarkers. This comprehensive analysis underscores the value of integrating a culture-based approach with a genome-based approach to provide complementary insights and therapeutic targets in IBD.

23 March 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
HPHyunjoon Park
Hyunjoon Park
JKJung Soo Kim
Jung Soo Kim
Dong Joon KimDong Joon Kim
Dong Joon Kim
KSKi Tae Suk
Ki Tae Suk
Advances in sequencing technologies have transformed human microbiome research, yet most analyses still rely on species-level profiles. However, strains rather than species represent the true ecological and functional units of the microbiome. Individual strains can vary substantially in gene content, metabolic capacity, virulence factors, antimicrobial resistance, and host-interaction properties. These differences critically influence immune responses, epithelial barrier integrity, disease susceptibility, and therapeutic outcomes. Here, we synthesize recent human microbiome studies that provide robust strain-resolved evidence, focusing on three major themes: (i) the emergence and long-term persistence of personalized strain repertoires, (ii) strain-specific pathobiont traits that drive host pathology, and (iii) the implications of strain-level ecology for the development of next-generation microbiome therapeutics. We also highlight key methodological innovations including high-resolution amplicon profiling, advanced metagenomic and single-cell genomics, and culture-based functional approaches that collectively enable strain-level resolution and are reshaping the field.

12 February 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
KHKwon Goo Hyun
Kwon Goo Hyun
HPHyunjoon Park
Hyunjoon Park
HKHyeong Seop Kim
Hyeong Seop Kim
Ki Kwang OhKi Kwang Oh
Ki Kwang Oh
JEJung A Eom
Jung A Eom
KSKi Tae Suk
Ki Tae Suk
Alterations in gut microbiota are closely associated with alcohol-associated liver disease (ALD) progression. We aimed to identify ALD-related bacterial strains with therapeutic or diagnostic potential. Human fecal samples were analyzed to screen candidate microbes, and an ALD mouse model was used to evaluate their effects. We also assessed bacterial DNA levels in blood to explore diagnostic utility. Lactobacillus helveticus and L. lactis treatment improved gut dysbiosis and reduced hepatic inflammation and endotoxemia. In contrast, Veillonella dispar, which is significantly enriched in ALD patients, had no beneficial effects in vivo. Instead, V. dispar abundance in blood distinguished ALD patients from controls with an area under the ROC curve of 0.815. These findings suggest that L. helveticus and L. lactis may be effective probiotics for ALD, while V. dispar may serve as a non-invasive diagnostic biomarker. Targeting microbiota may offer a new approach for ALD prevention and diagnosis.

12 August 2026 in Microorganisms
Verified
Journal Article
Open access
PDF file
RLRAN LEE
RAN LEE
HPHylung-Chul Park
Hylung-Chul Park
CHChul Sung Huh
Chul Sung Huh
HPHyunjoon Park
Hyunjoon Park
HSHyeon-Woo Sim
Hyeon-Woo Sim
HPHyun Jung Park
Hyun Jung Park
Breast milk-derived lactic acid bacteria (LAB) are promising sources of functional postbiotics. In this study, we evaluated the immunomodulatory, epithelial barrier-enhancing, and anti-melanogenic properties of nonviable HUH02 preparations, including heat-killed cells (HUH02-HK) and microfluidized preparations generated at 20,000 psi (HUH02-2psi) and 40,000 psi (HUH02-4psi), derived from the breast milk-derived Lactobacillus paragasseri HUH02 (L. paragasseri HUH02). HUH02 derivatives were evaluated in RAW264.7 macrophages, HaCaT keratinocytes, and B16F1 melanoma cells. All exhibited low cytotoxicity at functional concentrations. In Lipopolysaccharide (LPS)-stimulated RAW264.7 macrophages, HUH02 derivatives markedly reduced nitric oxide production and suppressed the expression of inflammatory mediators, restored macrophage morphology toward a non-activated phenotype, and reduced iNOS protein expression. In HaCaT keratinocytes, HUH02 derivatives enhanced wound closure and the expression of epithelial barrier-associated genes, including ZO-1 and Occludin. Moreover, microfluidized derivatives, particularly HUH02-2psi and HUH02-4psi, significantly enhanced transepithelial electrical resistance, indicating improved epithelial barrier integrity. In B16F1 melanoma cells, HUH02-derived preparations exhibited antimelanogenic effects by reducing intracellular melanin accumulation and suppressing the expression of melanogenesis-related genes and proteins, including Tyr, TRP-1, TRP-2, and MITF. HUH02 was identified as L. paragasseri based on 16S rRNA, average nucleotide identity, and whole-genome phylogenetic analyses. Genome-based safety assessment revealed the absence of antibiotic resistance genes, virulence factors, plasmid replicons, and pathogenicity-associated markers. These findings demonstrated that breast milk-derived L. paragasseri HUH02 postbiotics exhibit multifunctional biological activities, including immunomodulatory, epithelial barrier-enhancing, and antimelanogenic effects.